721 |
Crush vs. Culotte: When to Choose and How to Do? |
Andrejs Erglis |
May. 15. 12 |
720 |
Medina Classification |
Alfonso Medina |
May. 15. 12 |
719 |
Bioabsorble Stents: Promising Future?: Con: Limited Applicability for Complex Lesions |
Pawel E. Buszman |
May. 15. 12 |
718 |
Bioabsorble Stents: Promising Future?: Pro: Long-term Patency Is Good |
Jacques J. Koolen |
May. 15. 12 |
717 |
Current DES System Is Sufficient.: No, New Technology Is Still Evolving. |
Bernard R. Chevalier |
May. 15. 12 |
716 |
Current DES System Is Sufficient.:Yes, Current DES Is Enough. |
Ian T. Meredith |
May. 15. 12 |
715 |
Rivaroxaban in ACS |
Marc S. Sabatine |
May. 15. 12 |
714 |
Viable Role in ACS or PCI Patients: Combination of Anticoagulant and Antiplatelet Is Still Attractive Approach. |
David R. Holmes |
May. 15. 12 |
713 |
Drug Eluting Stent Will Be Most Promising in Lower Limb Arterial Disease |
Mark W. Burket |
May. 15. 12 |
712 |
Drug Eluting Balloon Will Be Most Promising in Lower Limb Arterial Disease |
Andrej Schmidt |
May. 15. 12 |